SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-012182
Filing Date
2022-05-12
Accepted
2022-05-12 17:17:53
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20220331_10q.htm   iXBRL 10-Q 1361712
2 EXHIBIT 10.1 ex_367377.htm EX-10.1 13644
3 EXHIBIT 31.1 ex_355934.htm EX-31.1 14575
4 EXHIBIT 31.2 ex_355935.htm EX-31.2 14670
5 EXHIBIT 32.1 ex_355936.htm EX-32.1 7115
6 EXHIBIT 32.2 ex_355937.htm EX-32.2 7387
  Complete submission text file 0001437749-22-012182.txt   6573655

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20220331.xsd EX-101.SCH 62687
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20220331_cal.xml EX-101.CAL 40761
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20220331_def.xml EX-101.DEF 394939
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20220331_lab.xml EX-101.LAB 374881
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20220331_pre.xml EX-101.PRE 416277
54 EXTRACTED XBRL INSTANCE DOCUMENT kmph20220331_10q_htm.xml XML 1098921
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 22919018
SIC: 2834 Pharmaceutical Preparations